Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Basal CD34+ Cell Count Predicts Peripheral Blood Hematopoietic Progenitor Cells Mobilization in Healthy Donors after Administration of G-CSF

Massimo Martino, MD, Mercedes Gori, Annalisa Pitino, Antonella Dattola, Roberta Fedele, MD, Giuseppe Alberto Gallo, Santina Barillà, Antonella Pontari, Giuseppe Irrera, MD, Giuseppe Messina, MD, Tiziana Moscato, Giuseppe Console, MD, Fortunato Morabito, Giovanni Tripepi

Blood (2016) 128 (22): 3380.

https://doi.org/10.1182/blood.V128.22.3380.3380

Published: 2016

Journal Articles

A Phase 2 Study of Bendamustine Plus Melphalan Conditioning for Second Autologous Stem Cell Transplantation in "De-Novo" Multiple Myeloma Patients in a Tandem Transplant Strategy

Massimo Martino, MD, Messina Giuseppe, MD, Roberta Fedele, MD, Giuseppe Irrera, MD, Console Giuseppe, MD, Giuseppe Alberto Gallo, Iolanda Donatella Vincelli, Francesca Ronco, Massimo Gentile, MD, Fortunato Morabito, MD

Blood (2015) 126 (23): 3197.

https://doi.org/10.1182/blood.V126.23.3197.3197

Published: 2015

Journal Articles

Bendamustine Plus Melphalan As Conditioning Regimen for Second Autologous Stem Cell Transplantation in Patients with Multiple Myeloma: Single Centre Experience

Massimo Martino, MD, Giuseppe Messina, MD, Tiziana Moscato, MD, Roberta Fedele, MD, Giuseppe Console, MD, Giuseppe Console, MD, Iolanda Donatella Vincelli, MD, Francesca Ronco, MD, Giuseppe Irrera, MD

Blood (2014) 124 (21): 2516.

https://doi.org/10.1182/blood.V124.21.2516.2516

Published: 2014

Journal Articles

Biosimilar Compared with Originator Filgrastim for Autologous Stems CELL Mobilisation: A Prospective-Historical Control Study in Multiple Myeloma REAL-Life Setting

Massimo Martino, MD, Tiziana Moscato, MD, Iolanda Donatella Vincelli, MD, Francesca Ronco, Roberta Fedele, MD, Giuseppe Irrera, MD, Giuseppe Console, MD, Giuseppe Messina, MD, Eugenio Piro, MD, Stefano Molica, MD, Fortunato Morabito, MD

Blood (2014) 124 (21): 5825.

https://doi.org/10.1182/blood.V124.21.5825.5825

Published: 2014

Journal Articles

Safety of Peripheral Hematopoietic Stem Cell Mobilization with Lenograstim in Allogeneic Healthy Donors ≥ 50 Years Old: A Single-Centre Experience

Massimo Martino, MD, Antonella Dattola, Roberta Fedele, MD, Antonella Pontari, Tiziana Moscato, MD, Maria Cuzzola, Tiziana Martinello

Blood (2014) 124 (21): 3844.

https://doi.org/10.1182/blood.V124.21.3844.3844

Published: 2014

Journal Articles

Nilotinib For Steroid-Refractory Chronic Graft Versus Host Disease (SR-cGVHD): Preliminary Results Of a Phase I-II GITMO Study (Gruppo Italiano Trapianto di Midollo Osseo)

Attilio Olivieri, Prof., Michele Cimminiello, MD, PhD, Ivana Latesoriere, Pietro Leoni, Francesco Onida, MD, Roberta Fedele, MD, Paolo Corradini, Vincenzo Pavone, Roberta Nuccorini, Sara Pasquina Pascale, Jacopo Olivieri, Giorgia Mancini, MD, Sonia Mammoliti, Alessandro Rambaldi, MD

Blood (2013) 122 (21): 4608.

https://doi.org/10.1182/blood.V122.21.4608.4608

Published: 2013

Journal Articles

At-Home Management of Aplastic Phase Following High-Dose Melphalan and Autologous Haematopoietic Stem Cell Transplantation for Multiple Myeloma Patients: A Pilot Study

Massimo Martino, MD, Grazia Pellicano’, MD, Tiziana Moscato, MD, Elisabetta Massara, MD, Roberta Fedele, MD, Giuseppe Console, MD, Letteria Russo, Miss, Giuseppe Messina, MD, Rosalba Di Filippo Scali, Giuseppe Irrera, MD

Blood (2011) 118 (21): 4497.

https://doi.org/10.1182/blood.V118.21.4497.4497

Published: 2011

NARROW

Basal CD34+ Cell Count Predicts Peripheral Blood Hematopoietic Progenitor Cells Mobilization in Healthy Donors after Administration of G-CSF

A Phase 2 Study of Bendamustine Plus Melphalan Conditioning for Second Autologous Stem Cell Transplantation in "De-Novo" Multiple Myeloma Patients in a Tandem Transplant Strategy

Bendamustine Plus Melphalan As Conditioning Regimen for Second Autologous Stem Cell Transplantation in Patients with Multiple Myeloma: Single Centre Experience

Biosimilar Compared with Originator Filgrastim for Autologous Stems CELL Mobilisation: A Prospective-Historical Control Study in Multiple Myeloma REAL-Life Setting

Safety of Peripheral Hematopoietic Stem Cell Mobilization with Lenograstim in Allogeneic Healthy Donors ≥ 50 Years Old: A Single-Centre Experience

Nilotinib For Steroid-Refractory Chronic Graft Versus Host Disease (SR-cGVHD): Preliminary Results Of a Phase I-II GITMO Study (Gruppo Italiano Trapianto di Midollo Osseo)

At-Home Management of Aplastic Phase Following High-Dose Melphalan and Autologous Haematopoietic Stem Cell Transplantation for Multiple Myeloma Patients: A Pilot Study

Email alerts

ASH Publications

American Society of Hematology

Basal CD34+ Cell Count Predicts Peripheral Blood Hematopoietic Progenitor Cells Mobilization in Healthy Donors after Administration of G-CSF

A Phase 2 Study of Bendamustine Plus Melphalan Conditioning for Second Autologous Stem Cell Transplantation in "De-Novo" Multiple Myeloma Patients in a Tandem Transplant Strategy

Bendamustine Plus Melphalan As Conditioning Regimen for Second Autologous Stem Cell Transplantation in Patients with Multiple Myeloma: Single Centre Experience

Biosimilar Compared with Originator Filgrastim for Autologous Stems CELL Mobilisation: A Prospective-Historical Control Study in Multiple Myeloma REAL-Life Setting

Safety of Peripheral Hematopoietic Stem Cell Mobilization with Lenograstim in Allogeneic Healthy Donors ≥ 50 Years Old: A Single-Centre Experience

Nilotinib For Steroid-Refractory Chronic Graft Versus Host Disease (SR-cGVHD): Preliminary Results Of a Phase I-II GITMO Study (Gruppo Italiano Trapianto di Midollo Osseo)

At-Home Management of Aplastic Phase Following High-Dose Melphalan and Autologous Haematopoietic Stem Cell Transplantation for Multiple Myeloma Patients: A Pilot Study

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only